Showing results (31-40 of 57) with videos related to
Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2019
Role of KEAP1/NFE2L2 Mutations in the Chemotherapeutic Response of Patients with Non-Small Cell Lung CancerYoungtae Jeong, Jessica A Hellyer, Henning Stehr, et al.Clinical Lung Cancer|July 15, 2011
Results from a single institution phase II trial of concurrent docetaxel/carboplatin/radiotherapy followed by surgical resection and consolidation docetaxel/carboplatin in stage III non-small-cell lung cancerMillie Das, Jessica S Donington, James Murphy, et al.Lung Cancer (Amsterdam, Netherlands)|May 5, 2012
ERCC1 expression in circulating tumor cells (CTCs) using a novel detection platform correlates with progression-free survival (PFS) in patients with metastatic non-small-cell lung cancer (NSCLC) receiving platinum chemotherapyMillie Das, Jonathan W Riess, Paul Frankel, et al.JTO Clinical and Research Reports|November 19, 2025
DLL3 Immunohistochemical Expression in Neuroendocrine-Transformed EGFR-Mutant Lung Cancer and Two Cases of Tarlatamab TherapyJacqueline V Aredo, Surbhi Singhal, Gerald J Berry, et al.Clinical Lung Cancer|December 8, 2023
Patient Selection and Outcomes for Hypofractionated Accelerated Radiation and Concurrent Chemotherapy for Non-Small-Cell Lung CancerCaressa Hui, Cesar Marquez, Brianna Lau, et al.Clinical Lung Cancer|December 10, 2021
Chemotherapy Plus Immunotherapy Versus Chemotherapy Plus Bevacizumab Versus Chemotherapy Alone in EGFR-Mutant NSCLC After Progression on OsimertinibMaya N White, Andrew J Piper-Vallillo, Rebecca M Gardner, et al.International Journal of Radiation Oncology, Biology, Physics|June 2, 2022
Characterization of Metastatic Non-Small Cell Lung Cancer and Oligometastatic Incidence in an Era of Changing Treatment ParadigmsHyunsoo Joshua No, Neelufar Raja, Rie Von Eyben, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2023
Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) GuidelineHumera Khurshid, Nofisat Ismaila, Jessica Bian, et al.Practical Radiation Oncology|July 20, 2022
Isolated Nodal Recurrence After Definitive Stereotactic Ablative Radiation Therapy for Non-Small Cell Lung CancerMax Devine, David J Merriott, Hyunsoo J No, et al.Cancer Immunology, Immunotherapy : CII|July 2, 2024
The performance status gap in immunotherapy for frail patients with advanced non-small cell lung cancerJulie Tsu-Yu Wu, June Corrigan, Chloe Su, et al.Pageof 6